PS significantly inhibits the production of key inflammatory mediators, including IL-6, IL-8, prostaglandin E2 (PGE2), and vascular endothelial growth factor (VEGF), in IL-1β-stimulated FLSs from RA patients [132]. Here, VEGFA is linked to rheumatoid arthritis.